Tue, Jul 29, 2014, 11:11 AM EDT - U.S. Markets close in 4 hrs 49 mins

Recent

% | $
Click the to save as a favorite.

Arena Pharmaceuticals, Inc. Message Board

  • jdolby32 jdolby32 Mar 1, 2013 9:09 AM Flag

    The ultimate face-off has occurred - two armies staring each other down.

    I am simply amazed that there are still millions of shorts with news just a matter of days away. I don't believe the FDA is going to rescind their approval, or that Eisai is going to dissolve their partnership with ARNA. So what are these critters betting on - a disastrous launch, a rejection by the EU, what? The competition has stumbled out of the gate - no partner, poor acceptance, saddled with expenses and contracts, rejected twice in the EU, REMS labeling. Up until big institutions and funds started buying huge blocks, i.e., Wellington, Blackrock, Fidelity, etc., the shorts had the potential to scare retail out of their shares. Now these shorts are faced off against a very formidable opponent. They cannot manipulate this down nearly as easily to cover, because their foes will quickly step in and buy all the shares available as well. So . . .

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARNA
4.68+0.07(+1.52%)11:11 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.